Daphne Quimi Receives Stock Award at Amicus Therapeutics Inc (FOLD) — SEC Form 4, Jan 20, 2021
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
264K sh
259,408 → 264,140
Equity Change
+1.8%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Daphne Quimi CIK 0001543031 |
CFO
|
Daphne Quimi at Amicus Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Amicus Therapeutics Inc
| 2023-01-19 | Sell | -$152,444 | View |
| 2023-01-13 | Award | — | View |
| 2023-01-06 | - | — | View |
| 2023-01-04 | Award | — | View |
| 2022-09-06 | Sell | -$49,621 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2021-01-15 | A - Award/Grant | 9,502 A | — | 264,140 | Direct | |
| Common Stock | 2021-01-15 | F - Tax Payment | 4,770 D | $21.84 | -$104,153 | 259,370 | Direct |
Footnotes (1)
- F1
- Granted for the achievement of the 2018 PRSU TSR goal as determined by the Compensation and Leadership Development Committee of the Board of Directors. Show more
Related filings at Amicus Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
2
institutional managers reporting a position
Largest by reported value
- Ifp Advisors, Inc $11.5K
- Huntington National Bank $14
5%+ Holders · 13D/G
5 filers
-
Barclays Plc 5.7%
-
Ubs Group Ag 5.5%
-
Glazer Capital, Llc 0.0%
-
Black Rock, Inc. 7.4%
Other insiders at Amicus Therapeutics Inc
GET /v1/forms/4/0001209191-21-004472
API docs
View Original SEC Filing